Poolbeg Pharma PLC (AIM:POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 2.700
0.00 (0.00%)
Apr 17, 2025, 4:06 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 13.50 million as of April 17, 2025. Its market cap has decreased by -72.73% in one year.
Market Cap
13.50M
Enterprise Value
3.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.70
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 13.50M, a decrease of -74.88%. That is a compound annual growth rate of -30.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 13.50M | -61.97% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.59B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.12B |